SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,509 | -53.6% | 19,253 | -28.5% | 0.01% | -59.1% |
| Q2 2023 | $160,485 | -6.4% | 26,927 | -48.6% | 0.02% | -4.3% |
| Q1 2023 | $171,387 | -71.8% | 52,412 | -66.0% | 0.02% | -76.5% |
| Q4 2022 | $608,438 | +1.7% | 154,035 | +54.6% | 0.10% | +8.9% |
| Q3 2022 | $598,000 | -38.7% | 99,659 | -34.3% | 0.09% | +4.7% |
| Q2 2022 | $976,000 | -22.1% | 151,735 | 0.0% | 0.09% | -20.4% |
| Q1 2022 | $1,253,000 | +42.1% | 151,735 | +166.2% | 0.11% | +61.2% |
| Q4 2021 | $882,000 | -46.8% | 57,005 | -22.6% | 0.07% | -43.7% |
| Q3 2021 | $1,658,000 | – | 73,618 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trustees of Columbia University in the City of New York | 281,250 | $6,334,000 | 9.69% |
| Flagship Pioneering Inc. | 34,239,018 | $771,063,000 | 8.08% |
| Crestline Management, LP | 3,210,937 | $72,310,000 | 6.80% |
| SB Management Ltd | 2,209,004 | $49,747,000 | 5.10% |
| Omega Fund Management, LLC | 843,750 | $19,001,000 | 2.13% |
| HARVARD MANAGEMENT CO INC | 1,163,601 | $26,204,000 | 1.54% |
| Alphabet Inc. | 2,812,500 | $63,338,000 | 1.50% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 387,508 | $8,727,000 | 1.03% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $93,036,000 | 0.53% |
| Dragoneer Investment Group | 1,500,000 | $33,780,000 | 0.44% |